Literature DB >> 26440101

Correction: Multilevel Approach of a 1-Year Program of Dietary and Exercise Interventions on Bone Mineral Content and Density in Metabolic Syndrome - the RESOLVE Randomized Controlled Trial.

Daniel Courteix, João Valente-Dos-Santos, Béatrice Ferry, Gérard Lac, Bruno Lesourd, Robert Chapier, Geraldine Naughton, Geoffroy Marceau, Manuel João Coelho-E-Silva, Agnès Vinet, Guillaume Walther, Philippe Obert, Frédéric Dutheil.   

Abstract

Entities:  

Year:  2015        PMID: 26440101      PMCID: PMC4595444          DOI: 10.1371/journal.pone.0140307

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


× No keyword cloud information.
Figs 2 and 4 are incorrect. The authors have provided corrected versions here.
Fig 2

Changes (360 days) on total body bone mineral content (BMC) and density (BMD), lumbar spine BMC and BMD and femoral neck BMC and BMD for re, Re and rE groups.

re: moderate-resistance-moderate-endurance; Re: high-Resistance-moderate-endurance; rE: moderate-resistance-high-Endurance. There were no significant differences in BMD and BMC parameters between re, Re and rE participants across the intervention. Participants in the intervention did not have significantly greater or lower bone mass or density development than controls.

Fig 4

Compliance effect (360 days) on total body bone mineral density (BMD), lumbar spine BMD and femoral neck BMD for re, Re and rE groups.

re: moderate-resistance-moderate-endurance; Re: high-Resistance-moderate-endurance; rE: moderate-resistance-high-Endurance. *Compliant participants significantly different from non-compliants (p<0.05). ‡ Compliant participants significantly different from controls. § Significant difference Re compliants vs. rE compliants.

Changes (360 days) on total body bone mineral content (BMC) and density (BMD), lumbar spine BMC and BMD and femoral neck BMC and BMD for re, Re and rE groups.

re: moderate-resistance-moderate-endurance; Re: high-Resistance-moderate-endurance; rE: moderate-resistance-high-Endurance. There were no significant differences in BMD and BMC parameters between re, Re and rE participants across the intervention. Participants in the intervention did not have significantly greater or lower bone mass or density development than controls.

Compliance effect (360 days) on total body bone mineral density (BMD), lumbar spine BMD and femoral neck BMD for re, Re and rE groups.

re: moderate-resistance-moderate-endurance; Re: high-Resistance-moderate-endurance; rE: moderate-resistance-high-Endurance. *Compliant participants significantly different from non-compliants (p<0.05). ‡ Compliant participants significantly different from controls. § Significant difference Re compliants vs. rE compliants.
  1 in total

1.  Multilevel Approach of a 1-Year Program of Dietary and Exercise Interventions on Bone Mineral Content and Density in Metabolic Syndrome--the RESOLVE Randomized Controlled Trial.

Authors:  Daniel Courteix; João Valente-dos-Santos; Béatrice Ferry; Gérard Lac; Bruno Lesourd; Robert Chapier; Geraldine Naughton; Geoffroy Marceau; Manuel João Coelho-e-Silva; Agnès Vinet; Guillaume Walther; Philippe Obert; Frédéric Dutheil
Journal:  PLoS One       Date:  2015-09-16       Impact factor: 3.240

  1 in total
  2 in total

1.  Long-term cost reduction of routine medications following a residential programme combining physical activity and nutrition in the treatment of type 2 diabetes: a prospective cohort study.

Authors:  Charlotte Lanhers; Guillaume Walther; Robert Chapier; Bruno Lesourd; Geraldine Naughton; Bruno Pereira; Martine Duclos; Agnès Vinet; Philippe Obert; Daniel Courteix; Frédéric Dutheil
Journal:  BMJ Open       Date:  2017-04-16       Impact factor: 2.692

2.  Effects of a short residential thermal spa program to prevent work-related stress/burnout on stress biomarkers: the ThermStress proof of concept study.

Authors:  Frédéric Dutheil; Elodie Chaplais; Audrey Vilmant; Denise Lanoir; Daniel Courteix; Pascale Duche; Armand Abergel; Daniela M Pfabigan; Shihui Han; Laurie Mondillon; Guillaume T Vallet; Martial Mermillod; Gil Boudet; Philippe Obert; Omar Izem; Yves Boirie; Bruno Pereira; François-Xavier Lesage
Journal:  J Int Med Res       Date:  2019-09-11       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.